Skip to main content
SpringerLink
Log in

Review of Lifestyle and CAM for Miscellaneous Urologic Topics (OAB and/or Incontinence, Pediatric Urology, Peyronie’s Disease, Premature Ejaculation, UTIs, Miscellaneous): Part Two

  • Chapter
  • First Online:
Complementary & Alternative Medicine for Prostate and Urologic Health

  • 918 Accesses

Abstract

Multiple lifestyle changes have the ability to prevent OAB and incontinence, including the ability to go beyond Kegel exercises for improvement utilizing more rigorous weight loss and core abdominal exercises. Even side effects of primary prostate cancer treatments appear to be greatly attenuated with these methods and with overall improvement in cardiovascular health. Pediatric urology is beginning to feel the impact of obesity, and methods to curb this epidemic could be derived from urology. Cranberry for UTI prevention in pediatrics appears to have some data, but as with adults the caloric contribution and compliance are concerning, and perhaps concentrated low-calorie supplements are emerging as a better alternative. Peyronie’s disease has several CAM options to be utilized with conventional treatment. Over-the-counter anesthetics are an option for some men with premature ejaculation as well as several SSRI-like CAM mimics that need more research. UTIs apart from cranberry supplements are being inundated by a variety of probiotics claiming success, but few can be recommended right now with good confidence. In the meantime, the impacts of lifestyle changes on most of urologic conditions are arguably profound enough to garner a Nobel Prize if they were truly appreciated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McGrother CW, Donaldson MM, Thompson J, Wag A, Tincello DG, Manktelow BN. Etiology of overactive bladder: a diet and lifestyle model for diabetes and obesity in older women. Neurourol Urodyn. 2012;31:487–95.

    Article  PubMed  Google Scholar 

  2. Chancellor MB, Oefelein MG, Vasavada S. Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release. Neurourol Urodyn. 2010;29:551–4.

    Article  PubMed  Google Scholar 

  3. Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative trial. J Urol. 2009;182:1055–61.

    Article  PubMed  CAS  Google Scholar 

  4. Vecchioli-Scaldazza C, Morosetti C, Berouz A, Giannubilo W, Ferrara V. Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study. Gynecol Obstet Invest. 2013;75:230–4.

    Article  PubMed  Google Scholar 

  5. Burton C, Saija A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn. 2012;31:1206–16.

    Article  PubMed  CAS  Google Scholar 

  6. Wing RR, West DS, Grady D, Creasman JM, Richter HE, Myers D, Program to Reduce Incontinence by Diet and Exercise Group, et al. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol. 2010;184:1005–10.

    Article  PubMed  Google Scholar 

  7. Park SW, Kim TN, Nam JK, Ha HK, Shin DG, Lee W, et al. Recovery of overall exercise ability, quality of life, and continence after 12-week combined exercise intervention in elderly patients who underwent radical prostatectomy: a randomized controlled study. Urology. 2012;80:299–305.

    Article  PubMed  Google Scholar 

  8. Thomas RJ, Holm M, Williams M, Bowman E, Bellamy P, Andreyev J, et al. Lifestyle factors correlate with the risk of late pelvic symptoms after prostatic radiotherapy. Clin Oncol (R Coll Radiol). 2013;25:246–51.

    Article  CAS  Google Scholar 

  9. Bower WF, Diao M. Acupuncture as a treatment for nocturnal enuresis. Auton Neurosci. 2010;157:63–7.

    Article  PubMed  CAS  Google Scholar 

  10. Bower WF, Diao M, Tang JL, Yeung CK. Acupuncture for nocturnal enuresis in children: a systematic review and exploration of rationale. Neurourol Urodyn. 2005;24:267–72.

    Article  PubMed  Google Scholar 

  11. Guven A, Giramonti K, Kogan BA. The effect of obesity on treatment efficacy in children with nocturnal enuresis and voiding dysfunction. J Urol. 2007;178: 1458–62.

    Article  PubMed  Google Scholar 

  12. Schaeffer AJ, Feng Z, Trock BJ, Mathews RI, Neu AM, Gearhart JP, et al. Medical comorbidities associated with pediatric kidney stone disease. Urology. 2011;77:195–9.

    Article  PubMed  Google Scholar 

  13. Kokorowski PJ, Routh JC, Hubert KC, Graham DA, Nelson CP. Association of urolithiasis with systemic conditions among pediatric patients at children’s hospitals. J Urol. 2012;188(4 Suppl):1618–22.

    Article  PubMed  Google Scholar 

  14. Salo J, Uhari M, Helminen M, Korppi M, Nieminen T, Pokka T, et al. Cranberry juice for the prevention of recurrences of urinary tract infections in children: a randomized placebo-controlled trial. Clin Infect Dis. 2012;54:340–6.

    Article  PubMed  Google Scholar 

  15. Afshar K, Stothers L, Scott H, MacNelly AE. Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial. J Urol. 2012;188(4 Suppl):1584–7.

    Article  PubMed  CAS  Google Scholar 

  16. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10, CD001321.

    PubMed  Google Scholar 

  17. Moyad MA. Promoting wellness for prostate cancer. 4th ed. Ann Arbor, MI: Spry; 2013.

    Google Scholar 

  18. Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology. 2001;57:26–9.

    Article  PubMed  CAS  Google Scholar 

  19. Yang SS, Chiang IN, Lin CD, Chang SJ. Advances in non-surgical treatments for urinary tract infections in children. World J Urol. 2012;30:69–75.

    Article  PubMed  CAS  Google Scholar 

  20. Lee SJ, Shim YH, Cho SJ, Lee JW. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol. 2007;22:1315–20.

    Article  PubMed  Google Scholar 

  21. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al. Antibiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307:1959–69.

    Article  PubMed  CAS  Google Scholar 

  22. Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA. 2007;298:179–86.

    Article  PubMed  CAS  Google Scholar 

  23. Paulis G, Brancato T, D’Ascenzo R, De Giorgio G, Nupieri P, Orsolini G, et al. Efficacy of vitamin E in the conservative treatment of Peyronie’s disease: legend or reality? A controlled study of 70 cases. Andrology. 2013;1:120–8.

    Article  PubMed  CAS  Google Scholar 

  24. Hatzimouratidis K, Eardley I, Giuliano F, Hatzichriststou D, Moncada I, Salonia A, et al. EAU guidelines on penile curvature. Eur Urol. 2012;62: 543–52.

    Article  PubMed  Google Scholar 

  25. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39–51.

    Article  PubMed  CAS  Google Scholar 

  26. Klein EA, Thompson Jr IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E cancer prevention trial (SELECT). JAMA. 2011;306:1549–56.

    Article  PubMed  CAS  Google Scholar 

  27. Bazzano C, de Angeles S, Kleist G, Macedo N. Allergic contact dermatitis from topical vitamins A and E. Contact Dermatitis. 1996;35:261–2.

    Article  PubMed  CAS  Google Scholar 

  28. Kosari P, Allkhan A, Sockolov M, Feldman SR. Vitamin E and allergic contact dermatitis. Dermatitis. 2010;21:148–53.

    PubMed  CAS  Google Scholar 

  29. Biagotti G, Cavallini G. Acetyl-L-carnitine vs. tamoxifen in the oral therapy of Peyronie’s disease: a preliminary report. BJU Int. 2001;88:63–7.

    Article  Google Scholar 

  30. Cavallini G, Biagiotti G, Koverech A, Vitali G. Oral propionyl-L-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie’s disease. BJU Int. 2002;89:895–900.

    Article  PubMed  CAS  Google Scholar 

  31. Safarinejad MR, Hosseini SY, Kolahi AA. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie’s disease: a double-blind, placebo controlled, randomized study. J Urol. 2007;178:1398–403.

    Article  PubMed  CAS  Google Scholar 

  32. Safarinejad MR. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie’s disease: a double-blind, placebo-controlled randomized study. Int J Impot Res. 2010;22:298–309.

    Article  PubMed  CAS  Google Scholar 

  33. Wyman M, Leonard M, Morledge T. Coenzyme Q10: a therapy for hypertension and statin-induced myalgia? Cleve Clin J Med. 2010;77:435–42.

    Article  PubMed  Google Scholar 

  34. Safarinejad MR. Efficacy and safety of omega-3 for treatment of early-stage Peyronie’s disease: a prospective, randomized, double-blind placebo-controlled study. J Sex Med. 2009;6:1743–54.

    Article  PubMed  CAS  Google Scholar 

  35. Abern MR, Larsen S, Levine LA. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie’s disease. J Sex Med. 2012;9: 288–95.

    Article  PubMed  CAS  Google Scholar 

  36. Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie’s fibrotic plaque and related fibroblast cultures. Nitric Oxide. 2003;9:229–44.

    Article  PubMed  CAS  Google Scholar 

  37. Ciociola F, Colpi GM. Peyronie’s disease: a “triple oxygenant therapy”. Arch Ital Urol Androl. 2013;85: 36–40.

    Article  PubMed  Google Scholar 

  38. Fitch 3rd WP, Easterling WJ, Talbert RL, Bordovsky MJ, Mosier M. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie’s disease-a placebo-controlled pilot study. J Sex Med. 2007;4:477–84.

    Article  PubMed  CAS  Google Scholar 

  39. Choi HK, Jung GW, Moon KH, Xin ZC, Choi YD, Lee WH, et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology. 2000;55:257–61.

    Article  PubMed  CAS  Google Scholar 

  40. Choi HK, Xin ZC, Choi YD, Lee WH, Mah SY, Kim DK. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int J Impot Res. 1999;11:261–4.

    Article  PubMed  CAS  Google Scholar 

  41. Moyad MA. Dr. Moyad’s guide to male sexual health. Ann Arbor, MI: Spry; 2012.

    Google Scholar 

  42. Thomas CA, Tyagi S, Yoshimura N, Chancellor MB, Tyagi P. Effect of hyperforin-enriched extract on pro-ejaculatory effect of 8-hydroxy-2-(di-N-propylamino)tetralin in anesthetized rats. Urology. 2007;70:813–6.

    Article  PubMed  Google Scholar 

  43. Nahas R, Sheikh O. Complementary and alternative medicine for the treatment of major depressive disorder. Can Fam Physician. 2011;57:659–63.

    PubMed  Google Scholar 

  44. Birdsall TC. 5-hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev. 1998; 3:271–80.

    PubMed  CAS  Google Scholar 

  45. Iovieno N, Dalton ED, Fava M, Mischoulon D. Second-tier natural antidepressants: review and critique. J Affect Disord. 2011;130:343–57.

    Article  PubMed  CAS  Google Scholar 

  46. Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytrptophan. Pharmacol Ther. 2006;109: 325–38.

    Article  PubMed  CAS  Google Scholar 

  47. McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012;4:233–51.

    Article  PubMed  Google Scholar 

  48. McMahon CG. Dapoxetine for premature ejaculation. Expert Opin Pharmacother. 2010;11:1741–52.

    Article  PubMed  CAS  Google Scholar 

  49. Dording CM, Mischoulon D, Shyu I, Alpert JE, Papakostas GI. SAMe and sexual functioning. Eur Psychiatry. 2012;27:451–545.

    Article  PubMed  CAS  Google Scholar 

  50. Burton TD, Liday C. The comparison of combination SSRI and PDE-5 inhibitor therapy to SSRI monotherapy in men with premature ejaculation. Ann Pharmacother. 2011;45:1000–4.

    Article  PubMed  CAS  Google Scholar 

  51. Choi HK, Seong DH, Rha KH. Clinical efficacy of Korean red ginseng for erectile dysfunction. Int J Impot Res. 1995;7:181–6.

    PubMed  CAS  Google Scholar 

  52. Choi YD, Park CW, Jang J, Kim SH, Jeon HY, Kim WG, et al. Effects of Korean ginseng berry extract on sexual function in men with erectile dysfunction: a multicenter, placebo-controlled, double-blind clinical study. Int J Impot Res. 2013;25:45–50.

    Article  PubMed  CAS  Google Scholar 

  53. Sunay D, Sunay M, Aydogmus Y, Bagbanci S, Arsian J, Karabulut A, et al. Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebo-controlled clinical trial. Eur Urol. 2011;59:765–71.

    Article  PubMed  CAS  Google Scholar 

  54. Bonetta A, Di Pierro FD. Enter-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma. Cancer Manag Res. 2012;4:281–6.

    PubMed  Google Scholar 

  55. Kontiokari T, Laitinen J, Jarvi L, Pokka T, Sundqvist K, Uhari M. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr. 2003;77: 600–4.

    PubMed  CAS  Google Scholar 

  56. Grin PM, Kowalewska PM, Alhazzan W, Fox-Robichaud AE. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol. 2013;20:6607–14.

    PubMed  Google Scholar 

  57. Saliba W, Barnett-Griness O, Rennert G. The association between obesity and urinary tract infection. Eur J Intern Med. 2013;24:127–31.

    Article  PubMed  CAS  Google Scholar 

  58. Dasgupta P, Chandiramani V, Parkinson MC, Beckett A, Fowler CJ. Treating the human bladder with capsaicin: is it safe? Eur Urol. 1998;33:28–31.

    Article  PubMed  CAS  Google Scholar 

  59. De Ridder D, Chandiramani V, Dasgupta P, Van Poppel H, Baert L, Fowler CJ. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term follow-up. J Urol. 1997;158:2087–92.

    Article  PubMed  Google Scholar 

  60. de Seze M, Wiart L, Ferriere J, de Seze MP, Joseph P, Barat M. Intravesical instillation of capsaicin in urology: a review of the literature. Eur Urol. 1999;36: 267–77.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Michigan Medical Center, Ann Arbor, MI, USA

    Mark A. Moyad M.D., M.P.H.

Authors
  1. Mark A. Moyad M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Moyad, M.A. (2014). Review of Lifestyle and CAM for Miscellaneous Urologic Topics (OAB and/or Incontinence, Pediatric Urology, Peyronie’s Disease, Premature Ejaculation, UTIs, Miscellaneous): Part Two. In: Complementary & Alternative Medicine for Prostate and Urologic Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8492-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8492-9_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8491-2

  • Online ISBN: 978-1-4614-8492-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation